M15-563
ClinicalTrials.gov NCT03391765
Research payments
$3,394,784
Through program year 2020, $3,394,784 in research payments was reported against M15-563, across 394 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03391765
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $408,370 | 52 |
| 2019 | Research | $2,986,414 | 342 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Rajeev Kumar Englewood, CO Named on 119 payments
- Daniel Claassen Nashville, TN Named on 23 payments
- Theresa Zesiewicz Tampa, FL Named on 21 payments
- David Geldmacher Birmingham, AL Named on 17 payments
- Nikolaus McFarland Gainesville, FL Named on 15 payments
- Irene Litvan Louisville, KY Named on 14 payments
- Deborah Hall Chicago, IL Named on 13 payments
- Jared Brosch Indianapolis, IN Named on 13 payments
- Lawrence Golbe New Brunswick, NJ Named on 12 payments
- John Slevin Lexington, KY Named on 11 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.